Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model.
PLOS ONE (2014)
  • Johnnie J. Orozco, Fred Hutchinson Cancer Research Center
  • Ethan R. Balkin, University of Washington
  • Ted A. Gooley, Fred Hutchinson Cancer Research Center
  • Aimee Kenoyer, Fred Hutchinson Cancer Research Center
  • Donald K. Hamlin, University of Washington
  • D. Scott Wilbur, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Mark D. Hylarides, Fred Hutchinson Cancer Research Center
  • Mazyar Shadman, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
February 12, 2014
DOI
10.1371/journal.pone.0113601
Citation Information
Johnnie J. Orozco, Ethan R. Balkin, Ted A. Gooley, Aimee Kenoyer, et al.. "Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model." PLOS ONE Vol. 9 Iss. 12 (2014)
Available at: http://works.bepress.com/john-pagel/107/